Overview

An Observational Study to Investigate Clinical Usefulness of OROS Hydromorphone in Korean Cancer Patients

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This study aims to collect clinical information and to examine the usefulness and safety of ORal Osmotic System Hydromorphone in Korean cancer patients. The decision to treat patients with drug is as per physician discretion and that doses are determined based upon approved labeling recommendations and physician discretion.
Details
Lead Sponsor:
Janssen Korea, Ltd., Korea
Treatments:
Hydromorphone